Meet Our Advisers
Dr. Paul M. DeLuca
Dr. DeLuca joined the faculty of the University of Wisconsin-Madison in 1971. He has served as a professor in the departments of Medical Physics, Radiology, Human Oncology, Engineering Physics and Physics. He now serves as Provost and Vice Chancellor for Academic Affairs. DeLuca’s research interests have concentrated on fast neutron dosimetry, including production of intense sources of fast neutrons, determination of elemental neutron kerma factors and application of microdosimetry to radiation dosimetry. He is vice chairman of the International Commission on Radiation Units and Measurements at Los Alamos. DeLuca received his B.S. in physics and math in 1966 and a Ph.D. in nuclear physics from the University of Notre Dame in 1971.
Mr. Wucherpfenning is president of Baker Construction Enterprises, Inc. Prior to joining Baker in 2010, he served as CEO of Phillips-Medisize, a global leader in outsource design, development, and technology-driven manufacturing for drug delivery, medical device, and medical diagnostic products. Wucherpfennig served as the executive vice president and chief operating officer of Schwing America, Inc., a member of the Schwing Group, a worldwide designer, manufacturer and distributor of concrete production and handling equipment. His career began with Ernst & Young in Minnesota, where he performed client audits as a CPA. After his time in public accounting, he served as the director of international finance for Synder General Corp., a designer and manufacturer of commercial and industrial air conditioning and handling equipment. Wucherpfennig has a degree in finance and accounting from the University of Wisconsin-Madison and holds an M.B.A. from the University of Minnesota. He has served on numerous boards in the construction, manufacturing, and medical technology industries.
Frederick Robertson, M.D.
Dr. Robertson is a seasoned corporate director and health care executive in the medical device, life science, and pharmaceutical industries. He has been a Venture Partner at Baird Capital since 2011 and retired from the anesthesiology faculty at the University of Wisconsin School of Medicine and Public Health in 2018. Previously, Robertson held the role of CEO and director of TomoTherapy Inc. before that company was acquired in 2011. Prior to joining TomoTherapy, Robertson served in a variety of roles in the medical industry, including president and CEO of GE Marquette Medical Systems and later as CEO of GE Medical Systems, as well as management positions with Marquette Medical Systems, including president and CEO. He served as a director of Lantheus Holdings from 2016-2021. He serves on the board of directors of the University of Wisconsin Foundation; the Morgridge Institute for Research; Alpha Source, Inc.; Ensodata, Inc.; Elucent, Inc.; and Zurex Pharma, Inc. Robertson received his M.B.A. from San Diego State University and earned his M.D. from University of Wisconsin Medical School.
Harrison Schmitt, Ph.D.
Dr. Schmitt has a diverse professional background, having served as a geologist, pilot, astronaut, businessman, writer, and U.S. Senator. Selected for the Scientist-Astronaut Program in 1965, he served as a mission scientist in support of the Apollo 11 mission. After training as backup lunar module pilot for Apollo 15, Schmitt flew in space as lunar module pilot for Apollo 17, the last Apollo mission to the moon. He was the only scientist and the last of 12 men to step onto the moon. He served in the U.S. Senate, continues to work in science, aerospace and business, and chaired the NASA Advisory Council from 2005-2008. Schmitt serves as adjunct professor of engineering at the University of Wisconsin-Madison. In addition to being active in considerations of space biomedical adaptation, he has worked in the biomedical field as acting CEO for the Lovelace Medical Foundation and is a director of PHDx Systems, a software developer and supplier for medical device outcomes. Schmitt is the author of “Return to the Moon” (Copernicus-Praxis 2006), a book advocating a private sector initiative to develop lunar helium-3 fusion power for use on Earth.
Connaughton is executive vice president of C3 Energy, which offers big data energy analytics solutions to utilities and to oil and gas companies. Prior to joining C3 Energy, Connaughton served as executive vice president and senior policy advisor of Exelon Corp., and executive vice president, corporate affairs, public and environmental policy for Constellation Energy. From 2001-09, Connaughton was chairman of the White House Council on Environmental Quality. In this capacity, he served on President Bush’s staff as Senior Environment, Energy and Natural Resources Advisor and as Director of the White House Office of Environmental Policy. He holds a bachelor’s degree from Yale University and a J.D. from Northwestern University School of Law.
Klug is the managing director of public affairs at the national law firm of Foley & Lardner LLP. He chairs the firm’s client service team. For eight years, Klug represented Madison, Wisconsin, in the U.S. House of Representatives, where he developed an expertise in health care, energy policy and financial services. He was appointed by President Bush for two terms to the Advisory Committee to the United States Trade Representative. Prior to his election to Congress, he was an Emmy award-winning reporter and anchor in Washington, D.C., Seattle, and his native Wisconsin. Klug is a novelist whose freelance writing has appeared in a number of U.S. newspapers and magazines. Before he joined Foley, he founded a regional magazine and book publishing company, which he sold in 2007. Klug holds an M.B.A. in finance from the University of Wisconsin, a master’s degree in journalism from Northwestern and a B.A. from Lawrence University.
Manuele is a results-oriented, innovative executive with 35 years of comprehensive U.S. and international expertise in nuclear medicine and medical isotope production. A longtime veteran of Amersham Health and GE Healthcare, he has launched core products, expanded products internationally, led the design, construction and FDA approval of two new U.S. manufacturing facilities, and held responsibility for several full-GMP radiopharmaceutical manufacturing sites across the United States and Europe. Before his retirement in 2008, Manuele served as general manager of global nuclear medicine supply chain for GE Healthcare, and general manager of Oncura, GE’s global I-125 brachytherapy seeds business. He has an impeccable track record of operational excellence, continuous profitability improvement, and implementation of industry-leading quality systems.
Donald J. Whelley
Whelley is the managing member of DJW Advisors, providing advisory services to institutional and high-net-worth clients. He has worked for more than 30 years in energy and financial services, providing valuation and advisory services and most recently supporting clients investing in other industry sectors including mining and biotech. After graduating with a B.S. in accounting from Clarkson University, Whelley began his professional career as an auditor for Arthur Andersen. His career has included accounting, finance and acquisition work for companies involved in oil and gas, agricultural biotech, broker dealer and syndication of real estate investments and energy consulting. In addition to being an advisor of SHINE, Whelley also serves as a director of Phoenix Nuclear Labs, a private manufacturer of commercial neutron generators; a director of GeoResources Inc., a Houston, Texas-based publicly traded exploration & production company; board observer of Dynamis Therapeutics, Inc., a private biotech company; board observer of Flugen, Inc., a private manufacturer of medical devices and vaccines; and advisory board member of Blue Ocean Consulting, Inc., an internet software and consulting firm.